Earnings release
Page 1
medicure 2-1250 Waverley Street Winnipeg , Manitoba , Canada R3T 6C6 Phone : 204-487-7412 Fax : 204-488-9823 MEDICURE REPORTS FINANCIAL RESULTS FOR THE SECOND QUARTER ENDED JUNE WINNIPEG , CANADA - 30 , 2021 ( August 27 , 2021 ) Medicure Inc. ( " Medicure " or the " Company " ) ( TSXV : MPH , OTC : MCUJF ) , a cardiovascular pharmaceutical company , today reported its results from operations for the quarter ended June 30 , 2021 . Quarter Ended June 30 , 2021 Highlights : • • Recorded total net revenue from the sale of products of $ 5.09 million during the second quarter ended June 30 , 2021 compared to $ 2.68 million for the second quarter ended June 30 , 2020 ; Recorded total net revenue from the sale of AGGRASTATⓇ of $ 2.8 million during the second quarter ended June 30 , 2021 compared to $ 2.6 million for the second quarter ended June 30 , 2020 ; Net loss for the second quarter ended June 30 , 2021 was $ 639,000 compared to net income of $ 19,000 for the second quarter ended June 30 , 2020 ; Adjusted earnings before interest , taxes , depreciation , and amortization ( EBITDA¹ ) for the second quarter ended June 30 , 2021 was $ 158,000 compared to adjusted EBITDA of $ 263,000 for the second quarter ended June 30 , 2020 Financial Results Net revenues for the three months ended June 30 , 2021 were $ 5.09 million compared to $ 2.68 million for the three months ended June 30 , 2020. Net revenues from AGGRASTATⓇ for the three months ended June 30 , 2021 were $ 2.8 million compared to $ 2.6 million for the three months ended June 30 , 2020. ZYPITAMAGⓇ contributed $ 403,000 for the three months ended June 30 , 2021 compared to $ 103,000 for the three months ended June 30 , 2020. Marley Drug ™ , TM which was acquired in December 2020 , contributed $ 1.87 million for the three months ended June 30 , 2021. Additionally , sodium nitroprusside ( SNP ) , contributed $ 22,000 , during the three months ended June 30 , 2021 , compared to $ 17,000 during the three months ended June 30 , 2020 . Net revenues for the six months ended June 30 , 2021 were $ 10.02 million compared to $ 5.3 million for the six months ended June 30 , 2020. Net revenues from AGGRASTATⓇ for the six months ended June 30 , 2021 were $ 5.4 million compared to $ 5.3 million for the six months ended June 30 , 2020. ZYPITAMAGⓇ contributed $ 564,000 for the six months ended June 30 , 2021 compared to $ 266,000 for the six months ended June 30 , 2020. Marley Drug ™ contributed $ 3.97 TM 1